Since its establishment in Canada more than a decade ago, Ceva Animal Health has remained steadfastly committed to providing farmers and veterinarians with treatments and support services to help prevent disease and maintain animals’ health and quality of life – all of which contribute directly to the wider issue of public health and human welfare.
 

In keeping with that commitment, Ceva offers an expanding range of products and services that are relevant, efficient, effective and, above all, viable for producers and adapted to the needs of veterinarians.
 

The global consumer demand for pork meat requires the prevention and control of swine diseases, good reproduction management practices, and the development of novel solutions to promote the sustainable production of safe, high-quality pork.
 

To that end, Ceva has invested heavily, especially in R&D, to deliver a wide range of products and tools designed to help improve the health and well-being of pigs and ensure the sustainability and profitability of pork production in Canada and around the world. 
 

Our range of products includes vaccines, metabolism, anti-coccidial, anti-infectives, anti-inflammatory, reproductive support, and autogenous (custom) vaccines. Some of our most popular products include: Hyogen®, Circovac®, Forceris®, Gleptosil®, Tulaven®, Meloxidyl®, and Enzaprost® T.
 

Our team of knowledgeable professionals in swine health is engaged in your community. For more information on our products, animal health science, and Ceva Animal Health, please feel free to contact us at 1-800-510-8864 / (519) 650-9570 or service.canada@ceva.com
 

VACCINES FOR SWINE

Vaccination is an effective tool to help:

• Stimulate pigs’ immune system.
• Reduce the prevalence of infection.
• Decrease clinical signs and pathogen shedding.
• Optimize the physiological and economic performance of pigs.
   

Preventing disease through vaccination also contributes to decreasing the need for antimicrobials, which:

• Addresses current environmental, social, and economic issues.  
• Aligns with retailers’ and consumers’ expectations.  
• Meets regulatory requirements.
   

Ceva’s swine portfolio includes cutting-edge commercial vaccines and autogenous vaccines manufactured by Gallant Laboratories in Ontario. Our commercial vaccines provide protection against two widespread and costly respiratory diseases that compromise pigs’ health and performance:

• Enzootic pneumonia  caused by Mycoplasma hyopneumoniae 
• Porcine circovirus Type 2 (PCV2)  infection